Science & Enterprise subscription

Follow us on Twitter

  • A chart posted on Friday by Statista provides yet another sign our planet is getting dangerously warmer.… https://t.co/1B0EREH07R
    about 6 hours ago
  • New post on Science and Enterprise: Infographic – More Data Show a Warming Planet https://t.co/iRIgqrhUo5 #Science #Business
    about 6 hours ago
  • Capt. ‘Sully’ Sullenberger: Like Joe Biden, I Once Stuttered, Too. I Dare You to Mock Me. https://t.co/D82eEUPCys
    about 10 hours ago
  • New data show most sponsors of clinical trials are not reporting their results on time to a U.S. government web sit… https://t.co/q6CFgCz7dF
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Mediocre https://t.co/ZP0aVBptuH Report Rates https://t.co/qbWW6RJl6B #Science #Business
    about 1 day ago

Please share Science & Enterprise

Migraine Drug Developer Raises $82.5M in IPO

NASDAQ share price display

A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million in its initial public offering of common stock. . . . → Read More: Migraine Drug Developer Raises $82.5M in IPO

Two Biotechs Each Issue $300M+ IPOs

NASDAQ share price display

Two biotechnology enterprises in the U.S. issued their initial public stock offerings yesterday, with each company raising at least $300 million in their transactions. . . . → Read More: Two Biotechs Each Issue $300M+ IPOs

Genome Editing Biotech Raises $126M in IPO

NASDAQ share price display

A biotechnology company developing treatments for disease and enhanced agricultural products with genome editing is raising $126 million in its initial public offering, or IPO, of common stock. . . . → Read More: Genome Editing Biotech Raises $126M in IPO

Infographic – Tech IPOs Flat in 2018

Tech IPO pipeline

CB Insights recently issued its annual Tech IPO Report, showing the number of initial public stock offerings in the technology industries unchanged from 2017. . . . → Read More: Infographic – Tech IPOs Flat in 2018

RNA Biotech Raises $604M in IPO

NASDAQ share price display

Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million. . . . → Read More: RNA Biotech Raises $604M in IPO

Synthetic DNA Company Raising $70 Million in IPO

NASDAQ share price display

A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering. . . . → Read More: Synthetic DNA Company Raising $70 Million in IPO

Cancer T-Cell Start-Up Gains $150 Million in IPO

NASDAQ share price display

A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO

Multi-Drug Resistance Antibiotic Developer to Issue IPO

A three year-old company making new antibiotics to treat infections resistant to earlier antibiotics plans to raise some $75 million in its initial public stock offering. . . . → Read More: Multi-Drug Resistance Antibiotic Developer to Issue IPO

Cancer Gene Therapy Company Raises $85M in IPO

A developer of cancer immunotherapies that transfer gene treatments into patients with brain tumors is raising $85 million in its initial public stock offering. . . . → Read More: Cancer Gene Therapy Company Raises $85M in IPO

Medical Robotics Company Crowdfunding IPO

A medical robotics company spun-off from labs at MIT is issuing its initial public stock offering through equity crowdfunding, aiming to raise $15 million. . . . → Read More: Medical Robotics Company Crowdfunding IPO